University of Nebraska Medical Center

2024 Hematology Highlights: A Post-ASH Review

2024 Hematology Highlights: A Post-ASH Review

The University of Nebraska Medical Center has sponsored this regional conference for the last 17 years. This year's conference is designed to update the target audience on new treatments and management of acute and chronic leukemia, acute myeloid leukemia, multiple myeloma, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms, bleeding disorders, as well as myths and sciences behind dietary recommendations for patients with cancer as presented during the 2023 annual meeting of the American Society of Hematology. Presentations will be delivered by key leaders while allowing the opportunity for participants to be involved in the interactive question/answer sessions.

Conference Objectives

At the conclusion of this activity, the participant should be better able to:

  1. Articulate the mechanism of action surrounding new therapies and the process for appropriate patient selection when caring for those with hematologic malignancies and non-malignant hematologic disorders.
  2. Analyze emerging data regarding new clinical, genetic, and molecular prognostic factors, and how to use them for improved precision approaches for the treatment of hematologic malignancies.
  3. Discuss recent clinical trials that demonstrate a reduction of treatment intensity involving therapies such as a combination of pharmacologic strategies when caring for those with hematologic malignancies.
  4. Summarize the impact of the evidence-based findings from the 2023 ASH meeting surrounding the management of hematologic malignancies and other disorders of thrombosis and hemostasis in clinical practice.
  5. Recognize how to safely initiate and use BCL2 inhibitors and interpret the current recommendations for antimicrobial prophylaxis for patients with AML.
  6. Determine common nutritional and dietary misconceptions for patients diagnosed with cancer, including hematologic malignancies, while utilizing current evidence-based recommendations for diet and nutrition in patients with hematologic malignancies.
  7. Describe the roles and responsibilities of the health care team when managing hematologic malignancies from the assessment, evaluation, and management perspectives.

General Information

Registration Information

Registration Fees 

  • Physicians, Pharmacists, and Advanced Practice Practitioners – $100
  • Other health care professionals – $80
  • Fellows/Residents – FREE*


*To receive the fellows/resident rate, send an email to Brenda Ram verifying your student status.


Register Now


The deadline to register online is Jan. 26, 2024. 

If you need assistance with online registration, please call our Registration Office at 402-559-5929.


Once online registration is closed, you will only be able to register on-site for the walk-in fee of $175. Walk-in registrations will only be accepted if space is available; meals are not guaranteed.

Cancel/Refund Policy

If you need to cancel your registration, please email conted@unmc.edu no later than Jan. 26, 2024. There is a $25 processing fee for cancellations made by Jan. 26. Cancellations made after this date and registrants who fail to attend are responsible for the full registration fee.

Conference Directors

Vijaya Raj Bhatt, MBBS, MS

Associate Professor, Division of Oncology and Hematology, Department of Internal Medicine, UNMC

Vijaya Raj Bhatt, MBBS, MS
Christopher R. D'Angelo, MD

Assistant Professor, Division of Oncology and Hematology, Department of Internal Medicine, UNMC

Christopher R. D'Angelo, MD


Brenda Ram, CMP, CHCP

Director, Educational Programs
UNMC Center for Continuing Education


Brenda Ram, CMP, CHCP